Palliative Care Bonus: Families Feel Better Too

Palliative Care Bonus: Families Feel Better Too 

In their study, Dr El-Jawahri and her colleagues assessed patients with incurable lung and gastrointestinal cancers and 275 of their family members, friends, or loved ones who were identified as the primary caregiver.

The active intervention was a monthly palliative care meeting between medical staff and the advanced cancer patient. Although the primary caregiver was not required to attend the meetings, about 50% did so regularly, Dr El-Jawahri reported.

The primary caregiver was evaluated at enrollment and at 12 and 24 weeks using standard questionnaires for quality of life (Medical Outcomes Study Health Survey Short Form-36) and mood (Hospital Anxiety and Depression Scale).

At 12 weeks, caregivers of patients receiving early palliative care reported significantly fewer symptoms of depression than caregivers of patients receiving standard care. And vitality and social functioning were also significantly better for caregivers of patients receiving early palliative care

At 24 weeks, caregivers of patients receiving early palliative care continued to report fewer symptoms of depression, but for the other measures, the differences were not significant.

The specifics of the outcomes will be released during an oral presentation at the meeting.

“This study points out that we have so many ways to help patients and their families through treatment,” said presscast host and ASCO President Julie Vose, MD, MBA, from the University of Nebraska in Omaha.

“Palliative care helps the patient and the family caregivers,” Dr Vose explained.

A separate study of the impact of early palliative care on the patients in this cohort will be presented at the meeting.

The early integration of palliative care with standard treatment was associated with multiple benefits for the patients themselves, the researchers found, including improved quality of life, decreased depression, and more frequent end-of-life discussions.

This study was funded by the National Institutes of Health. Dr El-Jawahri and Dr Vose have disclosed no relevant financial relationships. A number of the study coauthors report financial relationships with industry.

American Society of Clinical Oncology (ASCO) 2016 Annual Meeting: Abstract 10131. To be presented June 6, 2016.

Follow Medscape senior journalist Nick Mulcahy

 

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s